未登录
分享
收藏Clinical efficacy of CDK4/6 inhibitor plus endocrine therapy in HR-positive/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trialsCDK4/6抑制剂联合内分泌治疗HR阳性/HER2-0和HER2-low-positive转移性乳腺癌的临床疗效: PALOMA-2和PALOMA-3试验的二次分析
Li, Huiyue; Wu, Yun; Zou, Haotian; Koner, Salil; Plichta, Jennifer K.; Tolaney, Sara M.; Zhang, Jian; He, You -Wen; Wei, Qingyi; Tang, Li; Zhang, Hui; Zhang, Baoshan; Guo, Yuanyuan; Chen, Xin; Li, Kan; Lian, Liyou; Ma, Fei; Luo, Sheng
分享
收藏
分享
收藏